PERBELLINI, Omar
 Distribuzione geografica
Continente #
NA - Nord America 3.510
EU - Europa 3.205
AS - Asia 1.243
SA - Sud America 17
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 7.991
Nazione #
US - Stati Uniti d'America 3.482
GB - Regno Unito 1.289
CN - Cina 982
SE - Svezia 378
DE - Germania 338
FR - Francia 242
IE - Irlanda 235
IT - Italia 224
FI - Finlandia 191
RU - Federazione Russa 137
SG - Singapore 125
UA - Ucraina 57
BE - Belgio 39
NL - Olanda 31
TR - Turchia 27
KR - Corea 24
CA - Canada 23
VN - Vietnam 15
IR - Iran 14
IN - India 13
JP - Giappone 13
AU - Australia 9
ES - Italia 8
BR - Brasile 7
HK - Hong Kong 7
RO - Romania 6
MX - Messico 5
NP - Nepal 5
CL - Cile 4
GR - Grecia 4
HU - Ungheria 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
KZ - Kazakistan 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
LV - Lettonia 2
NO - Norvegia 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
DK - Danimarca 1
EC - Ecuador 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.991
Città #
Southend 1.149
Chandler 584
Jacksonville 456
Woodbridge 421
Ann Arbor 397
Beijing 250
Dublin 235
Ashburn 233
New York 137
Wilmington 125
Houston 120
Jinan 94
Singapore 91
Lawrence 87
Princeton 87
Nanjing 79
Verona 69
Shenyang 63
Tianjin 49
Helsinki 47
Hebei 45
Falls Church 40
Brussels 37
Haikou 35
Hangzhou 32
Ningbo 32
Nanchang 31
Boardman 29
Zhengzhou 29
Changsha 28
Norwalk 24
Guangzhou 23
Seoul 23
Groningen 21
Taiyuan 21
Milan 20
Sindelfingen 20
Taizhou 18
Dearborn 17
Los Angeles 17
Düsseldorf 16
Jiaxing 16
Nürnberg 16
Fuzhou 15
Dong Ket 13
Bologna 12
Lanzhou 12
Manchester 12
Redmond 12
Seattle 12
Kent 11
Redwood City 11
Washington 10
Chicago 9
Tokyo 9
Dallas 8
Lancaster 8
San Mateo 8
Auburn Hills 7
Toronto 7
Ardabil 6
Augusta 6
Châtenay-Malabry 6
Enterprise 6
Leawood 6
Mestre 6
Moscow 6
Paris 6
Amsterdam 5
Cormano 5
Fremont 5
Parsa 5
Renton 5
Riva 5
Rome 5
San Francisco 5
Zanjan 5
Arezzo 4
Costa Mesa 4
Fairfield 4
Monmouth Junction 4
Montreal 4
Pieve di Soligo 4
Qingdao 4
Stockholm 4
São Paulo 4
Verdun 4
Athens 3
Cambridge 3
Changle 3
Clearwater 3
Colorno 3
Edinburgh 3
Hefei 3
Hong Kong 3
Irving 3
Isola della Scala 3
La Paz 3
Lima 3
Lissone 3
Totale 5.711
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 362
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 220
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 155
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 145
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 140
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 133
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 130
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 129
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 122
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 119
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 117
BCR-signaling profiles associated with prognosis and progression in B-CLL 114
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 114
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 114
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 113
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 113
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 109
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 108
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 105
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 104
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 104
Underdiagnosed systemic mastocytosis: The role of flow cytometry 101
BCR-signaling profiles associated with prognosis and progression in B-CLL 101
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 101
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 100
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 100
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 100
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 99
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 99
A quantitative study on the growth variability of tumour cell clones in vitro 98
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 97
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 96
Cross-talks within the innate immune system: the role of neutrophils 93
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 93
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 91
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 90
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 90
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 90
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 89
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 88
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 88
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 88
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 88
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 86
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 85
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 84
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 84
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 84
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 83
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 83
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 83
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 83
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 82
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 81
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 81
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 79
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 79
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 79
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 78
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 78
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 78
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 77
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 77
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 76
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 75
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 73
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 72
Neutrophil activation and survival are modulated by interaction with NK cells 71
null 70
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 70
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 69
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 68
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 67
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 66
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 64
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 62
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 59
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 58
null 55
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 53
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 47
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 46
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 44
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 43
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 41
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 40
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 38
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 27
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 21
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 15
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 14
Totale 8.078
Categoria #
all - tutte 24.197
article - articoli 12.082
book - libri 0
conference - conferenze 12.115
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020776 0 0 15 73 85 118 94 73 38 108 80 92
2020/2021887 80 141 49 110 96 95 13 49 33 13 172 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/2025274 95 149 30 0 0 0 0 0 0 0 0 0
Totale 8.078